Villains vs. Value - Horizon37 launches new report
What really works on Scale-up boards? Today, Horizon37 launches its exciting new report.
UK tech demonstrates resilience as startups navigate virus crisis
Figures compiled by Tech Nation and Dealroom for the Digital Economy Council show that investors continue to back some of the UK’s most promising tech teams, despite the challenges posed by COVID-19.
Equivital launches social distancing wearable for returning workers
Equivital, the company that develops professional wearable technology, has announced the launch of eqWave, a wearable social distancing device which enables workers to return to work with confidence.
Cambridgeshire charities scoop share of £1million fund
Eight charities based in Cambridgeshire - incuding two Cambridge Network members - have received donations of £1,000 each as part of the Movement for Good awards.
Coronavirus test wins funding from Innovate UK
Iceni Diagnostics, developers of a rapid test for coronavirus, is one of the 800 companies to benefit from a £20 million government fund. The fund is to support the development of ambitious technologies that will build UK resilience against long-term impact of the outbreak.
Shops set for slow start on 15 June as seven out of 10 say they wouldn’t feel comfortable, EY report reveals
As the coronavirus lockdown starts to lift across the UK and with more retailers set to reopen in England on 15 June, the second EY Future Consumer Index reveals that consumers remain deeply cautious about returning to the shops.
FlexEnable is a cofinitive #21toWatch Top21 winner
FlexEnable has been named in the cofinitive #21toWatch campaign. The award recognises the People, Companies, and the ‘Things’ that they create that are setting the standards in innovation and entrepreneurship across globe.
Fast changing habits - help on hand
Habits are changing fast, so Computer Tutoring has published a series of FREE Zoom Tutorials designed for busy people, who need to quickly get up and running using Zoom.
New trial seeks to improve survival rates for patients with COVID-19
A new trial is taking place at Addenbrooke’s Hospital in Cambridge to test whether COVID-19 patients with weak immune systems have a better chance of survival if they are injected with plasma from people who have successfully recovered from the virus.
Cresset and Inocardia to develop 'in silico' cardiac safety assay for drug candidate screening
Cresset Discovery Services, provider of contract research services for early phase discovery, and Inocardia, provider of cardiac safety testing models, are pleased to announce a one year collaboration to develop improved computational methods for cardiac safety assessment. This collaboration also includes the University of Coventry and UCB and is supported by EIT Digital.
CN Bio and Cambridge University identify novel regulatory pathway driving NASH
CN Bio, a leading cell culture company that has developed single and multi-organ microphysiological systems (MPS) that improve the accuracy and efficiency of drug discovery, today announced the publication of co-authored research led by researchers at the University of Cambridge in Nature Metabolism1, identifying a novel pathway that regulates the underlying mechanism of Non-Alcoholic…
Kleinwort Hambros: How is COVID-19 changing the face of philanthropy?
Faced with answering the question, ‘How is Covid-19 changing the face of philanthropy?’, a panel that included Rebecca Constable revealed their impressions of how the world has changed and offered their impressions of where and how we go now.
Mexico City Police refresh critical communications solution with Sepura TETRA radios
Police in Mexico City have upgraded their critical communications devices to Sepura SC20 and STP9200 models, equipping their officers with modern, powerful TETRA radios. From December 2020, many of the city’s 46,000 officers will benefit from Sepura radios’ famed robustness, outstanding audio quality and reliable performance.
Avacta provides update on COVID-19 antigen diagnostic test development with Adeptrix
Avacta Group plc (AIM: AVCT), the developer of Affimer biotherapeutics and reagents, is pleased to announce that a BAMS™ (bead-assisted mass spectrometry) diagnostic test for the COVID-19 infection, being developed with its partner Adeptrix (Beverly MA, USA), has reached prototype stage and can detect the coronavirus spike protein in model samples in the concentration range appropriate for a…
'Multiple-shots-on-goal' approach needed to tackle Covid-19, say academics
A many-shots-on-goal approach – not command and control – will most effectively develop vaccines and treatments for COVID-19 (coronavirus), Cambridge Judge Business School academics say in a new 'California Management Review' article.
Barclays launches Back to Business toolkit for UK SMEs
Barclays has launched a toolkit to help small and medium sized enterprises (SMEs) across the UK get back on their feet as they navigate the uncertainty created by coronavirus.
Cambridge Index marginally declines
The Cambridge Index marginally fell by 3.2 points to close at 23687.8, as losses in Index heavyweights such as AVEVA Group and Abcam were offset by gains in DS Smith and Johnson Matthey.
Preliminary results from RECOVERY trial on the use of hydroxychloroquine in hospitalised patients with COVID-19
The ‘RECOVERY’ trial has released preliminary results showing no effect on mortality from the use of hydroxychloroquine in patients admitted to hospital with COVID-19.
Webinars investigate 'The digital (dis)comfort zone'
The University of Cambridge Trust & Technology Initiative and Cambridge Judge Business School are launching a networking webinar series on “The digital (dis)comfort zone”. There will be two webinars each month throughout the summer.
Display Graphics pivots business model to react to Covid-19
The local design and build business, Display Graphics, utilises its skills and expertise to provide social distancing products for places of work and leisure after being hard hit by the decimation of the worldwide live events industry.
Cambridge Science Centre joins nationwide campaign calling for government funding
Cambridge Science Centre, along with over 40 members of the UK Association for Science and Discovery Centres (ASDC), has joined the Science Centres For Our Future campaign, which is calling on the government to set up an Emergency Resilience Fund to support the UK’s world-class network of regional Science Centres.
What impact will Covid-19 have on the UK Government's loneliness strategy?
Graham Pendlebury, a former Director in the Department for Transport and a University of Cambridge Centre for Science and Policy (CSaP) Policy Fellow, discusses the impact of Covid-19 in relation to the UK Government's loneliness strategy.
Creativity in crisis
We’re more adaptable than we ever thought. Even in January this year the idea of working full-time from home, teaching our own kids or being unable to visit friends was unthinkable. Even in early March we were still carrying on fairly normally with life, at least in the UK. But with startling speed we have found ourselves in the grip of an unprecedented situation.
What is your purpose?
When reviewing your marketing plan, it is a good idea to go back to basics to understand what your business is about, what your company mission is and who you are trying to reach. Do you have a vision?
US2U Consulting uses emotional intelligence to help you develop high performing teams
One of the current priorities is to invest in Human Capital to deal with the many challenges that lie ahead. There is a need to develop Leadership and Management Skills and develop a culture of Lifelong Learning so that people can adapt to the new normal and make the most of the latest opportunities.